What’s the skinny on those pandemic pounds?

New study in the American Journal of Preventive Medicine sheds light on weight gain during the COVID-19 quarantine


Ann Arbor, April 4, 2022

More Americans weighed in as obese during the first year of the COVID-19 pandemic than in the previous year. A new study in the American Journal of Preventive Medicine, published by Elsevier, presents evidence from a large, nationally representative survey that documents this trend and helps to explain behavior changes that led to widespread weight gain in 2020.

“Previous studies present evidence that intra-pandemic changes in risky dietary and other health-related behaviors likely contributed to the rapid rise in body weight during this period. Adults who reported weight gain also reported more frequent snacking and alcohol intake; increased eating in response to sight, smell, and stress; and decreased physical activity,” explained lead investigator, Brandon J. Restrepo, PhD, US Department of Agriculture, Economic Research Service, Food Economics Division – Diet, Safety and Health Economics Branch, Washington, DC, USA.

Adult obesity in the US was elevated and trending upward prior to the COVID-19 pandemic. While several studies have reported on small and relatively homogenous online surveys that track weight gain in the US adult population during the initial pandemic period, this study is the first to use data from the Behavioral Risk Factor Surveillance System (BRFSS), a larger, nationally representative survey of the US adult population. It contains data on health outcomes, health-related risk behaviors, preventive services, and chronic medical conditions.

To estimate the overall changes in adult obesity prevalence and four obesity-related risk factors during the COVID-19 pandemic, the analysis of the BRFSS data employed linear regression models that control for age, sex, race/ethnicity, education, household income, marital status, number of children, survey year indicators, and state of residence indicators.

According to the analysis of more than 3.5 million US adults (aged 20 and older) from the 2011–2020 BRFSS, obesity was 3% more prevalent during the year beginning March 2020, compared with the 2019 to pre-pandemic 2020 period. The study also found statistically significant changes among US adults in four obesity-related risk factors during the COVID-19 pandemic: exercise participation, sleep duration, alcohol consumption, and cigarette smoking.

While exercise participation and sleep duration were higher by 4.4% and 1.5%, respectively, the number of days in which alcohol was consumed was 2.7% higher, and cigarette smoking prevalence was lower by 4%. The overall increases in exercise and sleep were not sufficient to offset the impact of other behaviors, resulting in an average 0.6% rise in body mass index during the COVID-19 pandemic. Although smoking cessation is a healthy step, it is known to cause some weight gain.

1247576 Percentage changes in obesity and obesity-related risk factors during the COVID-19 pandemic relative to the 2019 to pre-pandemic 2020 period. Source: Author’s calculations using data from the 2011-2020 Behavioral Risk Factors Surveillance System (Credit: Brandon J. Restrepo, PhD).

“Our results, which are broadly consistent with what prior studies have found using smaller and less representative samples, contribute additional insights that can serve to inform policymakers about the state of the US adult obesity epidemic and obesity-related risk factors,” noted Dr. Restrepo, adding, “Because obesity affects some adults more than others, it would be helpful to further explore the changes in the rates of adult obesity by demographic subgroup and socioeconomic status.”

---

Notes for editors
The article is“Obesity Prevalence Among U.S. Adults During the COVID-19 Pandemic,” by Brandon J. Restrepo, PhD (https://doi.org/10.1016/j.amepre.2022.01.012). It is published online in advance of the American Journal of Preventive Medicine, volume 63, issue 1 (July 2022), published by Elsevier and is openly available.

Full text of this article is also available to credentialed journalists upon request; contact Jillian B. Morgan at +1 734 936 1590 or ajpmmedia@elsevier.com. Jennifer Smits, Director of Communications at USDA, Economic Research Service may be reached for comment at jennifer.smits@usda.gov.

Findings and conclusions presented are those of the author and should not be construed to represent any official US Department of Agriculture (USDA) or US Government determination or policy. This research was supported by the USDA, Economic Research Service.

Elsevier’s Novel Coronavirus Information Center provides expert-curated information for researchers, healthcare professionals and public health officials, including clinical guidance and a portal to access all of Elsevier’s COVID-19 research. All resources are freely available. We also have dedicated hubs for healthcare professionals; health educators and students; librarians; and R&D professionals. You can find these in our Coronavirus Resource Directory.

About the American Journal of Preventive Medicine

The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials. www.ajpmonline.org

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com.

Media contact
Jillian B. Morgan, MPH, Managing Editor
AJPM
+1 734 936 1590
ajpmmedia@elsevier.com